136 related articles for article (PubMed ID: 35608729)
1. Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials.
Curtis A; Qu Y
Ther Innov Regul Sci; 2022 Sep; 56(5):744-752. PubMed ID: 35608729
[TBL] [Abstract][Full Text] [Related]
2. Building clinical trials around patients: Evaluation and comparison of decentralized and conventional site models in patients with low back pain.
Sommer C; Zuccolin D; Arnera V; Schmitz N; Adolfsson P; Colombo N; Gilg R; McDowell B
Contemp Clin Trials Commun; 2018 Sep; 11():120-126. PubMed ID: 30094387
[TBL] [Abstract][Full Text] [Related]
3. Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned.
Hanley DF; Bernard GR; Wilkins CH; Selker HP; Dwyer JP; Dean JM; Benjamin DK; Dunsmore SE; Waddy SP; Wiley KL; Palm ME; Mould WA; Ford DF; Burr JS; Huvane J; Lane K; Poole L; Edwards TL; Kennedy N; Boone LR; Bell J; Serdoz E; Byrne LM; Harris PA
J Clin Transl Sci; 2023; 7(1):e170. PubMed ID: 37654775
[TBL] [Abstract][Full Text] [Related]
4. Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework.
Izem R; Zuber E; Daizadeh N; Bretz F; Sverdlov O; Edrich P; Branson J; Degtyarev E; Sfikas N; Hemmings R
Ther Innov Regul Sci; 2024 May; 58(3):495-504. PubMed ID: 38315407
[TBL] [Abstract][Full Text] [Related]
5. Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.
Hirshberg JS; Huysman BC; Oakes MC; Cater EB; Odibo AO; Raghuraman N; Kelly JC
Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100478. PubMed ID: 34481996
[TBL] [Abstract][Full Text] [Related]
6. Remote Monitoring and Data Collection for Decentralized Clinical Trials.
Daly B; Brawley OW; Gospodarowicz MK; Olopade OI; Fashoyin-Aje L; Smart VW; Chang IF; Tendler CL; Kim G; Fuchs CS; Beg MS; Zhang L; Legos JJ; Duran CO; Kalidas C; Qian J; Finnegan J; Pilarski P; Keane H; Shen J; Silverstein A; Wu YL; Pazdur R; Li BT
JAMA Netw Open; 2024 Apr; 7(4):e246228. PubMed ID: 38607626
[TBL] [Abstract][Full Text] [Related]
7. Does pattern mixture modelling reduce bias due to informative attrition compared to fitting a mixed effects model to the available cases or data imputed using multiple imputation?: a simulation study.
Welch CA; Sabia S; Brunner E; Kivimäki M; Shipley MJ
BMC Med Res Methodol; 2018 Aug; 18(1):89. PubMed ID: 30157752
[TBL] [Abstract][Full Text] [Related]
8. Ethical Considerations in Decentralized Clinical Trials.
Bierer BE; White SA
J Bioeth Inq; 2023 Dec; 20(4):711-718. PubMed ID: 38427177
[TBL] [Abstract][Full Text] [Related]
9. The future of clinical trials-is it virtual?
Ng CE; Bowman S; Ling J; Bagshaw R; Birt A; Yiannakou Y
Br Med Bull; 2023 Dec; 148(1):42-57. PubMed ID: 37681298
[TBL] [Abstract][Full Text] [Related]
10. Clarifying selection bias in cluster randomized trials.
Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
[TBL] [Abstract][Full Text] [Related]
11. Opportunities and challenges with decentralized trials in Neuroscience.
Burger HU; Van de Casteele T; Rantell KR; Corey-Lisle P; Sfikas N; Abt M;
Biom J; 2023 Dec; 65(8):e2200370. PubMed ID: 37609878
[TBL] [Abstract][Full Text] [Related]
12. From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials.
Dulko D; Kwong M; Palm ME; Trinquart L; Selker HP
J Clin Transl Sci; 2023; 7(1):e236. PubMed ID: 38028335
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 pandemic on oncology clinical trial design, data collection and analysis.
Tang RS; Zhu J; Chen TT; Liu F; Jiang X; Huang B; Lee JJ; Beckman RA
Contemp Clin Trials; 2022 May; 116():106736. PubMed ID: 35331946
[TBL] [Abstract][Full Text] [Related]
14. What role can decentralized trial designs play to improve rare disease studies?
Moore J; Goodson N; Wicks P; Reites J
Orphanet J Rare Dis; 2022 Jun; 17(1):240. PubMed ID: 35725484
[TBL] [Abstract][Full Text] [Related]
15. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.
Tan AC; Ashley DM; Khasraw M
Clin Cancer Res; 2020 Jul; 26(13):3100-3103. PubMed ID: 32312892
[TBL] [Abstract][Full Text] [Related]
16. Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment.
Betcheva L; Kim JY; Erhun F; Oraiopoulos N; Getz K
Ther Innov Regul Sci; 2023 Sep; 57(5):1081-1098. PubMed ID: 37389795
[TBL] [Abstract][Full Text] [Related]
17. Methods and perceptions of success for patient recruitment in decentralized clinical studies.
Miyata BL; Tafuto B; Jose N
J Clin Transl Sci; 2023; 7(1):e232. PubMed ID: 38028356
[TBL] [Abstract][Full Text] [Related]
18. Estimators for handling COVID-19-related intercurrent events with a hypothetical strategy.
Lasch F; Guizzaro L
Pharm Stat; 2022 Nov; 21(6):1258-1280. PubMed ID: 35762230
[TBL] [Abstract][Full Text] [Related]
19. Recruitment for Remote Decentralized Studies in Parkinson's Disease.
Myers TL; Augustine EF; Baloga E; Daeschler M; Cannon P; Rowbotham H; Chanoff E; ; Jensen-Roberts S; Soto J; Holloway RG; Marras C; Tanner CM; Dorsey ER; Schneider RB
J Parkinsons Dis; 2022; 12(1):371-380. PubMed ID: 34744053
[TBL] [Abstract][Full Text] [Related]
20. Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance.
Howard L; Abdelnour C; Abner EL; Allegri RF; Dodge HH; Gauthier S; Hoyos CM; Jicha GA; Kehoe PG; Mummery CJ; Ogunniyi A; Scarmeas N; Chen X; Titiner JR; Weber CR; ; Peters R
Alzheimers Dement; 2024 Jun; ():. PubMed ID: 38824659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
